IN RE: ABILIFY (ARIPIPRAZOLE) PRODUCTS LIABILITY LITIGATION

  1. February 09, 2018

    Consumers Seek Sanctions For Destroyed Abilify Evidence

    Consumers suing Otsuka America Pharmaceutical Inc. over side effects of its antipsychotic drug Abilify asked a Florida federal judge Thursday to sanction the drugmaker for allegedly destroying important pre-2007 communications, saying Otsuka waited too long to disclose the lack of evidence it argues is crucial to its case.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!